Three new c-pyrones named marinactinones A-C (1-3) were isolated from marine-derived actinomycete Marinactinospora thermotolerans SCSIO 00606. These structures were elucidated by extensive spectroscopic methods. All three new compounds were evaluated for cytotoxic effects on six cancer cell lines and inhibitory activities of DNA topoisomerase II. Compounds 1-3 exhibited moderate cytotoxicities against SW1990, HepG2 and SMCC-7721 cell lines, and compound 2 showed weak DNA topoisomerase II inhibition activity. This is the first report on the chemical constituents and their biological activities from Marinactinospora, a novel genus of marine actinomycetes.
INTRODUCTION
Numerous secondary metabolites with novel structures and distinct biological activities have been discovered from marine actinomycetes, which represent new resources having great potential for novel drug exploration. [1] [2] [3] [4] In our efforts to search for new antitumor compounds, organic extracts of more than 2000 actinomycete strains isolated from sediments of the northern South China Sea were screened by brine shrimp lethality assays. 5, 6 Among them, the ethyl acetate extracts of a strain Marinactinospora thermotolerans SCSIO 00606 exhibited good cytotoxic activity. The subsequent chemical investigation on this strain resulted in the isolation of three new g-pyrone derivates, namely, marinactinones A-C (1-3).
g-Pyrone natural products constitute a large class of biologically active compounds, and most of them were derived from marine organisms. 7 To the best of our knowledge, marinactinones A-C (1-3) were the first three g-pyrone natural products with a methylhexyl side chain. Previously, we described M. thermotolerans as a novel marine actinobacterial genus. 8 Herein, we report the isolation, structure elucidation of the three new g-pyrones (1-3) from the strain M. thermotolerans SCSIO 00606, and we also evaluated the new compounds for their cytotoxicities against six human cancer cell lines and their potential to inhibit DNA topoisomerase II. This is the first report on the chemical constituents from this new group of marine microbes and their biological activities. (Table 1) , suggesting the molecular formula to be C 15 H 24 NO 3 . The 1D NMR data for 1 indicated one carbonyl, five quarternary carbons, one methine, four methylenes and five methyls. Heteronuclear single quantum coherence experiments revealed all the connective relationship between the proton and carbon signals in 1. The IR absorptions at 1670 and 1602 cm À1 , the absorption at 253.5 nm in the UV spectrum, together with the signals at d 99.3 (C-3, s), 118.2 (C-5, s), 158.4 (C-6, s) and 162.1 (C-2, s) p.p.m. in the 13 C NMR spectrum showed the presence of g-pyrone moiety. 9 Furthermore, the HMBC correlations from H-14 (d 1.84, s, 3H) to C-2, C-3 and C-4, from H-15 (d 1.93, s, 3H) to C-4, C-5 and C-6 and from 2-OMe (d 3.95, s, 3H) to C-2 ( Figure 2 ) confirmed that the skeleton of 1 is 6-substituted 2-methoxy-3,5-dimethyl-4H-pyrane-4-one. Detailed NMR analyses including 1D NMR, 1 H-1 H double-quantum-filtered correlation spectroscopy and HMBC, showed the presence of one methine, four methylenes and two methyls, indicating that the substitution at C-6 positions was a 5-methylhexyl group. The HMBC correlations from H-7 (d 2.58, t, J¼7. (Table 1) . Furthermore, the heteronuclear single quantum coherence and HMBC correlations also supported the corresponding changes ( Figure 2 ). Thus, compound 3 was established as 2-methoxy-3-methyl-5-ethyl-6-(4-methylhexyl)-4H-pyran-4-one. The C-10 was only one chiral center of compound 3, but we could not confirm its configuration for sample limitation.
RESULTS AND DISCUSSION
Compounds 1-3 were evaluated for their cytotoxicities against MCF-7, SW1990, HepG2, NCI-H460, SMCC-7721 and HeLa cancer cell lines with 5-fluorouracil as a positive control. From our observations, compounds 1-3 exhibited moderate cytotoxicities to SW1990, HepG2 and SMCC-7721, but no significant cytotoxicities to other cell lines (Table 2 ). Subsequently, compounds 1-3 were tested for inhibitory effects on in vitro DNA topoisomerase II enzymatic activity. Only compound 2 exhibited dose-dependent weak inhibition activity on topoisomerase II, with IC 50 value of 607 mM ( Figure 3 ).
METHODS General
Optical rotation was recorded on PerkinElmer Model 341 polarimeter (PerkinElmer Inc., Waltham, MA, USA). UV spectra were recorded on Beckman DU 640 spectrophotometer (Beckman Coulter Inc., Brea, CA, USA). IR spectra were taken on Bruker VECTOR22 IR spectrophotometer (Bruker Corporation, Ettlingen, Germany) in KBr disks. 1 H-, 13 C-NMR and DEPT spectra and 2D NMR were recorded on a Bruker AVANCE DRX-500 spectrometer using TMS as internal standard, and chemical shifts were 
Fermentation, extraction and isolation
The strain SCSIO 00606 was inoculated into 500 ml Erlenmeyer flasks containing150 ml liquid medium (soluble starch 10.0 g, yeast extract 10.0 g, KH 2 PO 4 The crude extract (20.0 g) was separated into 13 fractions on a silica gel column using a step gradient elution of petroleum ether/CHCl 3 /MeOH. The fraction 5 (753.2 mg) was subjected on Sephadex LH-20 eluting with CHCl 3 / MeOH (1:1), and thereafter followed by silica gel column chromatography using a stepwise gradient elution of petroleum ether-acetone, to yield subfraction 5-3-2 (117.0 mg). The subfraction 5-3-2 was further purified by semipreparative HPLC (75% MeOH, 3.0 ml min À1 ), to give compound 1 (5.0 mg, t R 16.9 min), 2 (4.5 mg, t R 21.8 min) and 3 (2.0 mg, t R 23.4 min). Table 1 ).
Physico-chemical properties

Cytotoxicity assays
Cytotoxicity was evaluated by the MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) method 10 using MCF-7, SW1990, HepG2, NCI-H460, SMCC-7721 and HeLa cell lines. The cell lines were grown in RPMI-1640 supplemented with 10% fetal bovine serum under a humidified atmosphere of 5% CO 2 and 95% air at 371C. A volume of 200 ml of those cell suspensions at a density of 1Â10 5 cells per ml was plated in 96-well microtiter plates and incubated for 24 h at the above condition. Then 2 ml of the test compound solutions (in DMSO) at different concentrations was added to each well and further incubated for 72 h in the same condition. A volume of 20 ml of the MTT solution (5 mg ml À1 in IPMI-1640 medium) was added to each well and incubated for 4 h. A volume of 150 ml of an old medium containing MTT was then gently replaced by DMSO and pipetted to dissolve any formazan crystals formed. Absorbance was then determined on a SpectraMax Plus plate reader (Molecular Devices Inc., Sunnyvale, CA, USA) at 570 nm.
Assay for topoisomerase II inhibition in vitro
Compounds 1-3 were also screened for their ability to inhibit topoisomerase II enzymatic activity, [11] [12] [13] with etoposide as positive control. The plasmid pBV220 was purified with the AxyPrep Plasmid midiPrep Kit (Axygen Biosciences, Union City, CA, USA) from ampicillin-resistant Escherichia coli. Active DNA topoisomerase II was obtained from SD (Sprague Dawley) rat liver cells. The reaction volumes were 20 ml in an assay buffer (200 mM Tris-HCl, pH 7.5, 340 mM KCl, 40 mM MgCl 2 , 20M dithiothreitol, 120 mg ml À1 bovine serum albumin and 4 mM ATP) containing 1 unit of topoisomerase II (2 ml) and 5 mg plasmid pBV220 (4 ml). Samples were solubilized using DMSO and tested for inhibitory activity at the final concentrations of 0, 12.5, 25, 50, 100, 200 and 400 mg ml À1 . The reaction mixtures were incubated at 37 1C for 30 min and terminated by adding 10 volume of loading buffer (5% sarkosyl, 0.0025% bromophenol blue, 25% glycerol). Reaction products were electrophoresed on a 0.7% agarose gel in Tris-acetate-EDTA running buffer containing ethidium bromide (0.5 mg ml À1 ) at 80 V for 30 min. For the visualizing and quantitative analyses of topoisomerase II activity, the gels were directly scanned with Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA) and the area representing supercoiled DNA was calculated. Concentrations for 50% inhibition (IC 50 ) were determined by interpolation from plots of topoisomerase II activity versus inhibitor concentration. New c-pyrones from marine actinomycete F Wang et al
